Published in Endocrinology on November 04, 2004
Differential regulation of gonadotropin-releasing hormone neuron activity and membrane properties by acutely applied estradiol: dependence on dose and estrogen receptor subtype. J Neurosci (2009) 1.28
Molecular evidence for a functional ecdysone signaling system in Brugia malayi. PLoS Negl Trop Dis (2010) 1.00
Estrogen and tamoxifen protect against Mn-induced toxicity in rat cortical primary cultures of neurons and astrocytes. Toxicol Sci (2009) 0.98
Hepatitis B virus X protein and the estrogen receptor variant lacking exon 5 inhibit estrogen receptor signaling in hepatoma cells. Nucleic Acids Res (2006) 0.98
A novel FADS1 isoform potentiates FADS2-mediated production of eicosanoid precursor fatty acids. J Lipid Res (2012) 0.97
Arsenic abrogates the estrogen-signaling pathway in the rat uterus. Reprod Biol Endocrinol (2010) 0.82
Selective Estrogen Receptor Modulation by Larrea nitida on MCF-7 Cell Proliferation and Immature Rat Uterus. Biomol Ther (Seoul) (2014) 0.79
The Role of Steroid Sulfatase as a Prognostic Factor in Patients with Endometrial Cancer. Yonsei Med J (2016) 0.75
Sentinel node biopsy in vulvar and vaginal melanoma: presentation of six cases and a literature review. Ann Surg Oncol (2002) 1.50
Disruption of estrogen receptor beta gene impairs spatial learning in female mice. Proc Natl Acad Sci U S A (2002) 1.47
ERbeta in breast cancer--onlooker, passive player, or active protector? Steroids (2008) 1.42
Underrepresentation of women in clinical trials: why gynecologic oncologists are worried. Obstet Gynecol (2015) 1.41
Mechanisms for pulsatile regulation of the gonadotropin subunit genes by GNRH1. Biol Reprod (2006) 1.31
Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways. Steroids (2008) 1.30
Differential regulation of gonadotropin-releasing hormone neuron activity and membrane properties by acutely applied estradiol: dependence on dose and estrogen receptor subtype. J Neurosci (2009) 1.28
Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells. Mol Endocrinol (2008) 1.20
Human papillomavirus vaccination recommendation may be linked to reimbursement: a survey of Virginia family practitioners and gynecologists. J Pediatr Adolesc Gynecol (2011) 1.08
The Use of p16 in enhancing the histologic classification of uterine smooth muscle tumors. Am J Surg Pathol (2008) 1.02
The calcium component of gonadotropin-releasing hormone-stimulated luteinizing hormone subunit gene transcription is mediated by calcium/calmodulin-dependent protein kinase type II. Endocrinology (2003) 1.02
Integration of steroid and growth factor pathways in breast cancer: focus on signal transducers and activators of transcription and their potential role in resistance. Mol Endocrinol (2007) 1.01
Preoperative hypoalbuminemia is an independent predictor of poor perioperative outcomes in women undergoing open surgery for gynecologic malignancies. Gynecol Oncol (2013) 0.96
Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells. Mol Endocrinol (2005) 0.95
Luteinizing hormone beta promoter stimulation by adenylyl cyclase and cooperation with gonadotropin-releasing hormone 1 in transgenic mice and LBetaT2 Cells. Biol Reprod (2007) 0.93
Effects of adjunctive Swedish massage and vibration therapy on short-term postoperative outcomes: a randomized, controlled trial. J Altern Complement Med (2003) 0.90
"See-and-treat" loop electrosurgical excision. Has the time come for a reassessment? J Reprod Med (2002) 0.90
Proteasome regulation of dynamic transcription factor occupancy on the GnRH-stimulated luteinizing hormone beta-subunit promoter. Mol Endocrinol (2008) 0.89
Small nuclear RING finger protein stimulates the rat luteinizing hormone-beta promoter by interacting with Sp1 and steroidogenic factor-1 and protects from androgen suppression. Mol Endocrinol (2004) 0.87
Estrogen enhances gonadotropin-releasing hormone-stimulated transcription of the luteinizing hormone subunit promoters via altered expression of stimulatory and suppressive transcription factors. Endocrinology (2007) 0.86
Use of cisplatin without desensitization after carboplatin hypersensitivity reaction in epithelial ovarian and primary peritoneal cancer. Am J Obstet Gynecol (2007) 0.83
Protein kinase A activation of estrogen receptor alpha transcription does not require proteasome activity and protects the receptor from ligand-mediated degradation. Endocrinology (2004) 0.83
Estrogen receptor-alpha (ERalpha), but not ERbeta, modulates estrogen stimulation of the ERalpha-truncated variant, TERP-1. Endocrinology (2002) 0.80
Thyrotropin-releasing hormone-stimulated thyrotropin expression involves islet-brain-1/c-Jun N-terminal kinase interacting protein-1. Endocrinology (2004) 0.80
A cost-effective analysis of adjuvant therapies for the treatment of stage I endometrial adenocarcinoma. Gynecol Oncol (2007) 0.80
Management for Elderly Women With Advanced-Stage, High-Grade Endometrial Cancer. Obstet Gynecol (2015) 0.79
Utilization of a uniform grading system for interpreting serous ovarian cancer. Am J Obstet Gynecol (2008) 0.78
AMP-activated protein kinase is a key intermediary in GnRH-stimulated LHβ gene transcription. Mol Endocrinol (2013) 0.78
Estrogen receptor-beta: why may it influence clinical outcome in estrogen receptor-alpha positive breast cancer? Breast Cancer Res (2007) 0.78
Predictors of suboptimal surgical cytoreduction in women treated with initial cytoreductive surgery for advanced stage epithelial ovarian cancer. Am J Obstet Gynecol (2005) 0.78
Cervical adenocarcinoma in situ: the predictive value of conization margin status. Am J Obstet Gynecol (2007) 0.78
Role of calcium-calmodulin-dependent protein kinase cascade in thyrotropin (TSH)-releasing hormone induction of TSH and prolactin gene expression. Endocrinology (2004) 0.77
Truncated estrogen receptor product-1 stimulates estrogen receptor alpha transcriptional activity by titration of repressor proteins. J Biol Chem (2003) 0.76
The role of in vitro directed chemotherapy in epithelial ovarian cancer. Rev Obstet Gynecol (2010) 0.76
Stimulation of the novel estrogen receptor-alpha intronic TERP-1 promoter by estrogens, androgen, pituitary adenylate cyclase-activating peptide, and forskolin, and autoregulation by TERP-1 protein. Endocrinology (2005) 0.76
Surgical management and postoperative treatment of endometrial carcinoma. Rev Obstet Gynecol (2008) 0.75
Timing of and Reasons for Unplanned 30-Day Readmission After Hysterectomy for Benign Disease. Obstet Gynecol (2016) 0.75
Risk factors for early-occurring and late-occurring incisional hernias after primary laparotomy for ovarian cancer. Obstet Gynecol (2015) 0.75
Current surgical management of endometrial cancer. Hematol Oncol Clin North Am (2011) 0.75
Association of Hospital Volume With Racial and Ethnic Disparities in Locally Advanced Cervical Cancer Treatment. Obstet Gynecol (2017) 0.75
Ninety-Day Mortality as a Reporting Parameter for High-Grade Serous Ovarian Cancer Cytoreduction Surgery. Obstet Gynecol (2017) 0.75